Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting 2022-11-07 14:38
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial 2022-11-07 10:04
China Marches into the Era of Interventional Direct Annuloplasty 2022-11-06 01:44
Waterdrop Launches Insurance against Breast Cancer Recurrence 2022-11-04 22:30
Waterdrop Wins the NBD "Annual Insurtech Progress Award" 2022-11-04 21:30
Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases 2022-11-04 20:00
Akeso Completes Enrollment in Phase III Trial of PD-1/VEGF Bispecific Antibody (AK112) Combined with Chemotherapy in EGFR-TKI-resistant nsq-NSCLC 2022-11-04 08:57
ASH 2022 | Ascentage Pharma to Present Initial Data of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Combination with BTK Inhibitors for the Treatment of R/R CLL/SLL, Including an ORR of 98%, in an Oral Report at the ASH Annual Meeting 2022-11-04 03:33
ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting 2022-11-04 03:32
Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition 2022-11-03 21:10
I-Mab Announces Two Poster Presentations of CD47 Antibody Lemzoparlimab at ASH 2022 2022-11-03 21:01
2nd Global Forum of People's Organizations on Hansen's Disease Focuses on Capacity Building to Promote Dignity of Those Affected by the Disease 2022-11-03 21:00
Yuyu Pharma attendance at European Pharmaceutical Conference 2022-11-03 21:00
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market 2022-11-03 19:30
Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation 2022-11-03 19:00
Eccogene Announces US IND Approval for GLP-1 Receptor Agonist ECC5004 2022-11-03 13:11
Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery 2022-11-02 13:55
WAT Medical Entrusted By Geely Auto To Develop Neuromodulation Technologies To Improve Travel Experiences 2022-11-02 01:15
I Peace partners with the California Institute for Regenerative Medicine [CIRM] 2022-11-02 00:00
Real-World Application of Lunit INSIGHT to be Spotlighted at RSNA 2022 (Oral Presentations) 2022-11-01 22:00
1 132 133 134 135 136 801